Medicine
Technescan PYP 11.9 mg/3.2 mg per 10 mL powder for injection
Technescan PYP 11.9 mg/3.2 mg per 10 mL powder for injection is a prescription medicine containing Sodium pyrophosphate and Stannous for intravenous use, marketed by Curium, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Before preparation, store the Technescan PYP reaction vial refrigerated at 2°C…
Key facts
- Active ingredient (INN)
- Sodium pyrophosphate and Stannous
- Brand
- Technescan PYP
- Strength
- 11.9 mg/3.2 mg per 10 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 5 vials
- Marketing authorisation holder
- Curium
- Manufacturer
- Curium
- Origin register
- US FDA, United States
- Storage
- Before preparation, store the Technescan PYP reaction vial refrigerated at 2°C to 8°C (36°F to 46°F). After preparation, store the vial at 20°C to 25°C (68°F to 77°F). If radiolabeled, store the vial in appropriate shielding to protect from radiation.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 October 2015
- Identifiers
- DailyMed set ID 304b63f4-a32e-4700-805d-5bc9f27e7d6aNDC 69945-094Application NDA017538
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial in 1 cello pack / 10 mL in 1 vial | 69945-094-20 | Curium | 14 October 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Sodium pyrophosphate and Stannous is a fixed-dose combination medicine indicated for skeletal imaging to demonstrate areas of altered osteogenesis in adults, among other approved uses. MedsAcross supplies Sodium pyrophosphate and Stannous for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium pyrophosphate and StannousFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Technescan PYP prescribing information (Curium) · U.S. National Library of Medicine, DailyMed
Need Technescan PYP 11.9 mg/3.2 mg per 10 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.